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Background: Familial Mediterranean fever (FMF) is the most common
hereditary inflammatory disease characterized by recurrent attacks of fever
and serositis. The most devastating complication of FMF is amyloidosis,
leading to chronic renal failure (CRF). The amyloid protein may accumu-
late in many tissues including the cartilage, particularly in the kidneys.
Sonographic femoral cartilage thicknesses (FCT) was evaluated in many
chronic rheumatic diseases and was shown to be thinner than healthy
individuals.
Objectives: The aim of this study was to determine FCT in FMF patients
and healthy individuals and to assess the relationship of FCT with the
development of amyloidosis and clinical features.
Methods: Patients diagnosed with FMF according to the Tel-Hashomer
criteria were included in the study. Patients with trauma and other inflam-
matory disease and patients with a history of knee operation were
excluded. Femoral cartilage thickness of both knees was measured with
a 7-12 MHz linear probe in maximum knee flexion. Three mid-point
measurement were obtained from each knees: lateral femoral condyle
(LFC), intercondylar area (ICA) and medial femoral condyle (MFC). Clinic
characteristics of the patients including disease duration, medications,
comorbid conditions, amyloidosis, CRF, FMF gene mutation, arthritis, sac-
roiliitis, PRAS score and physical activity scores were recorded. Descrip-
tive analysis was performed for all parameters. The Mann-Whitney U-test
and Spearman’s correlation coefficient were used in statistical analysis.
P<0.05 was considered statistically significant.
Results: A total of 45 patients with FMF (35 women, 10 men) and 20
age-sex-BMI matched controls (14 women, 6 men) were enrolled in this
study. The mean age of the patients and controls were 38.2 (SD:12.2)
and 37.5 (SD:8.5) years, respectivelly. Amyloidosis occurred in 7 patients
(15.6%), CRF in 3 (6.7%), sacroilitis in 10 (22.2%) and arthritis in 16
(35.6%). Disease activity was mild in 48.9%, moderate in 20% and
severe 22.2% of the patients. The mean FCT in centimeters values in
the FMF and control groups were as follows: on the right side LFC 0.19
(SD:0.03) and 0.22 (SD:0.05), ICA 0.23 (SD:0.05) and 0.24 (SD:0.06),
MFC 0.20 (SD:0.04) and 0.24 (SD:0.06); on the left side LFC 0.19
(SD:0.03) and 0.21 (SD:0.03), ICA 0.22 (SD:0.05) and 0.24 (SD:0.06),
MFC 0.19 (SD:0.03) and 0.22 (SD:0.04). Patients with FMF had
decreased cartilage thickness at the lateral condyle of both knees
(p<0.05) and medial condyle of the left knee (p<0.05) compared with
controls. FCT measurements were similar in patients with or without
arthritis, sacroiliitis, amyloidosis and CRF. Physical activity scores were
significantly correlated with the left LFC (r=0.309). Total protein in 24-
hour urine showed a highly negative correlation with left LFC (r=-0.718).
Conclusion: These findings suggest that patients with FMF have
decreased FCT compared with controls. There is no significant relation-
ship between the FCT and amyloidosis, it has significant relation with
proteinuria level.
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Background: Familial Mediterranean Fever (FMF) is the most common
monogenic autoinflammatory disease. Disease-specific symptoms are fever
and polyserositis attacks (1). The most important complication in the long
term is amyloidosis (2). Many cytokines and acute phase reactants have
been studied in patients with familial Mediterranean fever. Erythrocyte
sedimentation rate (ESR), c-reactive protein (CRP), serum amyloid A
(SAA) and fibrinogen levels increase during attack and return to normal
values after the attack (3,4). Biomarkers that are useful on the course of
the disease and the development of amyloidosis are still needed.
Objectives: In this study, we aimed to observe the changes reflected in
the hemogram parameter values during the remission and attack periods
of FMF patients.
Methods: Study included 67 patients who met the FMF Tel-Hashomer cri-
teria. The patients with available results of both remission and attack
periods were included in the study.Since the distribution of all continuous
variables used in the study as a statistical method was not suitable for
normal distribution, Wilcoxon T test was used to investigate the difference
in hematological variables during remission and attack periods
Results: 21 of the patients were male and 46 were female. The mean
age of the male patients was 41.57 ± 11.08 and the female patients
were 35.84 ± 11.75. The mean age of all patients was 38.18 ± 11.20
years. There was a statistically significant difference between neutrophils
in the comparisons of hematological variables between remission and epi-
sode periods of familial Mediterranean Fever patients (p <0.001). No sig-
nificant difference was found in terms of other variables (Table 1).
Conclusion: Our study does not support that neutrophil/lymphocyte ratio,
MPV and PDW values may be helpful in the attack. Significant differen-
ces in neutrophil counts suggest that further studies are needed to show
neutrophil cell morphology, number, and function in FMF patients.
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Abstract AB1088 Table 1. Distribution of hematological parameter characteristics of
patients with remission and attack episodes
n Remission Attack p
CRP(mg/L) 54 3.23 [3.03-4.20] 27.90 [17.60-51.10] <0.001
RDW(%) 54 16.10 [15.20-17.30] 16.00 [14.80-17.00] 0.157
MPV(fL) 54 7.52 [7.02-8.20] 7.50 [6.85-8.29] 0.054
PDW(%) 54 17.70 [17.30-18.30] 17.70 [17.20-18.20] 0.185












54 0.79 [0.57-1.47] 1.14 [0.90-1.25] 0.137
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